Celsion Corporation Invited to Present Poster at Cytokine-Based Cancer Immunotherapies Summit Celsion Corporation’s GEN-1 IL-12 Program in Advanced Ovarian Cancer to be Featured in Poster Presentation Chief Science Officer Dr. Khursheed Anwer to Present and Participate in Two Panel...